2018
DOI: 10.1113/jp275864
|View full text |Cite
|
Sign up to set email alerts
|

CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 30 publications
0
8
0
Order By: Relevance
“…Here, we utilised an endothelial lineage-tracing mouse to assess pulmonary EC responses to PAH with scRNA-seq. With a well-established mouse model of pulmonary hypertension which induces right ventricular hypertrophy and increased RVSP 5,6 , we elucidate the dynamic EC responses at a subpopulation level and across the arteriovenous axis. In addition, our dataset is available for interrogation at http://bakergroup.shinyapps.io/mouse_ec_pah.…”
Section: Cvr-2020-1310mentioning
confidence: 99%
See 2 more Smart Citations
“…Here, we utilised an endothelial lineage-tracing mouse to assess pulmonary EC responses to PAH with scRNA-seq. With a well-established mouse model of pulmonary hypertension which induces right ventricular hypertrophy and increased RVSP 5,6 , we elucidate the dynamic EC responses at a subpopulation level and across the arteriovenous axis. In addition, our dataset is available for interrogation at http://bakergroup.shinyapps.io/mouse_ec_pah.…”
Section: Cvr-2020-1310mentioning
confidence: 99%
“…Animal models have been developed to study the pathogenesis of PAH. The widely used SuHx mouse model, which utilises Sugen 5416 (SU5416) injection and chronic hypoxia (10% O2), leads to increased right ventricular systolic pressure (RVSP) and right ventricular hypertrophy 5,6 . Endothelial cells (ECs) are involved in the primary vascular changes leading to PAH 7 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Dr Penumatsa and colleagues value the Sugen 5416 injection and chronic hypoxia exposure (SuHx) mouse model for its contribution to the understanding of pulmonary arterial hypertension (PAH) signalling pathways and mechanisms (Penumatsa et al . ). They note that other imperfect animal models have provided insight about pathogenesis and contributed to the development of many therapeutic agents for PAH.…”
mentioning
confidence: 97%
“…As an example, this issue features a Cross‐Talk debate (Vitali, and Penumatsa et al . ) regarding the suitability of the murine model of pulmonary arterial hypertension using the combined insults of vascular endothelial growth factor receptor inhibition and hypoxic exposure as a model for human disease. A review of the literature conducted by Hu et al .…”
mentioning
confidence: 99%